250 related articles for article (PubMed ID: 28556564)
21. A review of lifestyle, metabolic risk factors, and blood-based biomarkers for early diagnosis of pancreatic ductal adenocarcinoma.
Pang Y; Holmes MV; Chen Z; Kartsonaki C
J Gastroenterol Hepatol; 2019 Feb; 34(2):330-345. PubMed ID: 30550622
[TBL] [Abstract][Full Text] [Related]
22. Significant association between ABO blood group and pancreatic cancer.
Greer JB; Yazer MH; Raval JS; Barmada MM; Brand RE; Whitcomb DC
World J Gastroenterol; 2010 Nov; 16(44):5588-91. PubMed ID: 21105191
[TBL] [Abstract][Full Text] [Related]
23. Does blood group affect survival following pancreatoduodenectomy for periampullary malignancy?
Khalil K; Bansal S; Ayaani S; Hodson J; Lam FT; Khan S; Ahmad J; Isaac J; Muiesan P; Mirza D; Dasari B; Marudanayagam R; Sutcliffe RP; Marangoni G; Roberts KJ
HPB (Oxford); 2018 Sep; 20(9):848-853. PubMed ID: 29705345
[TBL] [Abstract][Full Text] [Related]
24. Preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after curative intent surgical resection.
Kim NH; Kim HJ
Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):450-455. PubMed ID: 30237091
[TBL] [Abstract][Full Text] [Related]
25. ABO blood group and risk of pancreatic cancer: a study in Shanghai and meta-analysis.
Risch HA; Lu L; Wang J; Zhang W; Ni Q; Gao YT; Yu H
Am J Epidemiol; 2013 Jun; 177(12):1326-37. PubMed ID: 23652164
[TBL] [Abstract][Full Text] [Related]
26. Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability.
Shi HJ; Jin C; Fu DL
World J Gastroenterol; 2016 Dec; 22(45):10024-10037. PubMed ID: 28018110
[TBL] [Abstract][Full Text] [Related]
27. The Impact of Tumor Location on Resection and Survival for Pancreatic Ductal Adenocarcinoma.
Winer LK; Dhar VK; Wima K; Morris MC; Lee TC; Shah SA; Ahmad SA; Patel SH
J Surg Res; 2019 Jul; 239():60-66. PubMed ID: 30802706
[TBL] [Abstract][Full Text] [Related]
28. Pre-operative Plasma miR-21-5p Is a Sensitive Biomarker and Independent Prognostic Factor in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Surgical Resection.
Karasek P; Gablo N; Hlavsa J; Kiss I; Vychytilova-Faltejskova P; Hermanova M; Kala Z; Slaby O; Prochazka V
Cancer Genomics Proteomics; 2018; 15(4):321-327. PubMed ID: 29976637
[TBL] [Abstract][Full Text] [Related]
29. ABO blood group IgM isoagglutinins interact with tumor-associated O-glycan structures in pancreatic cancer.
Hofmann BT; Stehr A; Dohrmann T; Güngör C; Herich L; Hiller J; Harder S; Ewald F; Gebauer F; Tachezy M; Precht C; Izbicki JR; Bockhorn M; Wagener C; Wolters-Eisfeld G
Clin Cancer Res; 2014 Dec; 20(23):6117-26. PubMed ID: 25320359
[TBL] [Abstract][Full Text] [Related]
30. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer.
Amundadottir L; Kraft P; Stolzenberg-Solomon RZ; Fuchs CS; Petersen GM; Arslan AA; Bueno-de-Mesquita HB; Gross M; Helzlsouer K; Jacobs EJ; LaCroix A; Zheng W; Albanes D; Bamlet W; Berg CD; Berrino F; Bingham S; Buring JE; Bracci PM; Canzian F; Clavel-Chapelon F; Clipp S; Cotterchio M; de Andrade M; Duell EJ; Fox JW; Gallinger S; Gaziano JM; Giovannucci EL; Goggins M; González CA; Hallmans G; Hankinson SE; Hassan M; Holly EA; Hunter DJ; Hutchinson A; Jackson R; Jacobs KB; Jenab M; Kaaks R; Klein AP; Kooperberg C; Kurtz RC; Li D; Lynch SM; Mandelson M; McWilliams RR; Mendelsohn JB; Michaud DS; Olson SH; Overvad K; Patel AV; Peeters PH; Rajkovic A; Riboli E; Risch HA; Shu XO; Thomas G; Tobias GS; Trichopoulos D; Van Den Eeden SK; Virtamo J; Wactawski-Wende J; Wolpin BM; Yu H; Yu K; Zeleniuch-Jacquotte A; Chanock SJ; Hartge P; Hoover RN
Nat Genet; 2009 Sep; 41(9):986-90. PubMed ID: 19648918
[TBL] [Abstract][Full Text] [Related]
31. Variation at ABO histo-blood group and FUT loci and diffuse and intestinal gastric cancer risk in a European population.
Duell EJ; Bonet C; Muñoz X; Lujan-Barroso L; Weiderpass E; Boutron-Ruault MC; Racine A; Severi G; Canzian F; Rizzato C; Boeing H; Overvad K; Tjønneland A; Argüelles M; Sánchez-Cantalejo E; Chamosa S; Huerta JM; Barricarte A; Khaw KT; Wareham N; Travis RC; Trichopoulou A; Trichopoulos D; Yiannakouris N; Palli D; Agnoli C; Tumino R; Naccarati A; Panico S; Bueno-de-Mesquita HB; Siersema PD; Peeters PH; Ohlsson B; Lindkvist B; Johansson I; Ye W; Johansson M; Fenger C; Riboli E; Sala N; González CA
Int J Cancer; 2015 Feb; 136(4):880-93. PubMed ID: 24947433
[TBL] [Abstract][Full Text] [Related]
32. Doublecortin and CaM kinase-like-1 as an independent prognostic factor in patients with resected pancreatic carcinoma.
Nishio K; Kimura K; Amano R; Nakata B; Yamazoe S; Ohira G; Miura K; Kametani N; Tanaka H; Muguruma K; Hirakawa K; Ohira M
World J Gastroenterol; 2017 Aug; 23(31):5764-5772. PubMed ID: 28883702
[TBL] [Abstract][Full Text] [Related]
33. Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction.
Galeotti AA; Gentiluomo M; Rizzato C; Obazee O; Neoptolemos JP; Pasquali C; Nentwich M; Cavestro GM; Pezzilli R; Greenhalf W; Holleczek B; Schroeder C; Schöttker B; Ivanauskas A; Ginocchi L; Key TJ; Hegyi P; Archibugi L; Darvasi E; Basso D; Sperti C; Bijlsma MF; Palmieri O; Hlavac V; Talar-Wojnarowska R; Mohelnikova-Duchonova B; Hackert T; Vashist Y; Strouhal O; van Laarhoven H; Tavano F; Lovecek M; Dervenis C; Izbéki F; Padoan A; Małecka-Panas E; Maiello E; Vanella G; Capurso G; Izbicki JR; Theodoropoulos GE; Jamroziak K; Katzke V; Kaaks R; Mambrini A; Papanikolaou IS; Szmola R; Szentesi A; Kupcinskas J; Bursi S; Costello E; Boggi U; Milanetto AC; Landi S; Gazouli M; Vodickova L; Soucek P; Gioffreda D; Gemignani F; Brenner H; Strobel O; Büchler M; Vodicka P; Paiella S; Canzian F; Campa D
J Med Genet; 2021 Jun; 58(6):369-377. PubMed ID: 32591343
[TBL] [Abstract][Full Text] [Related]
34. ABO blood group and the risk of pancreatic cancer.
Wolpin BM; Chan AT; Hartge P; Chanock SJ; Kraft P; Hunter DJ; Giovannucci EL; Fuchs CS
J Natl Cancer Inst; 2009 Mar; 101(6):424-31. PubMed ID: 19276450
[TBL] [Abstract][Full Text] [Related]
35. Preoperative platelet to lymphocyte ratio predicts outcome of patients with pancreatic ductal adenocarcinoma after pancreatic resection.
Shirai Y; Shiba H; Sakamoto T; Horiuchi T; Haruki K; Fujiwara Y; Futagawa Y; Ohashi T; Yanaga K
Surgery; 2015 Aug; 158(2):360-5. PubMed ID: 26032829
[TBL] [Abstract][Full Text] [Related]
36. Pancreatic cancer susceptibility loci and their role in survival.
Rizzato C; Campa D; Giese N; Werner J; Rachakonda PS; Kumar R; Schanné M; Greenhalf W; Costello E; Khaw KT; Key TJ; Siddiq A; Lorenzo-Bermejo J; Burwinkel B; Neoptolemos JP; Büchler MW; Hoheisel JD; Bauer A; Canzian F
PLoS One; 2011; 6(11):e27921. PubMed ID: 22125638
[TBL] [Abstract][Full Text] [Related]
37. Preoperative cognitive function predicts survival in patients with resectable pancreatic ductal adenocarcinoma.
Baekelandt BM; Hjermstad MJ; Nordby T; Fagerland MW; Kure EH; Heiberg T; Buanes T; Labori KJ
HPB (Oxford); 2016 Mar; 18(3):247-54. PubMed ID: 27017164
[TBL] [Abstract][Full Text] [Related]
38. Pancreatic cancer incidence and outcome in relation to ABO blood groups among Han Chinese patients: a case-control study.
Ben Q; Wang K; Yuan Y; Li Z
Int J Cancer; 2011 Mar; 128(5):1179-86. PubMed ID: 20473916
[TBL] [Abstract][Full Text] [Related]
39. Single nucleotide polymorphism in the microRNA-199a binding site of HIF1A gene is associated with pancreatic ductal adenocarcinoma risk and worse clinical outcomes.
Wang X; Ren H; Zhao T; Ma W; Dong J; Zhang S; Xin W; Yang S; Jia L; Hao J
Oncotarget; 2016 Mar; 7(12):13717-29. PubMed ID: 26872370
[TBL] [Abstract][Full Text] [Related]
40. Central pancreatectomy for early-stage pancreatic ductal adenocarcinoma: a single-center case-control study.
Gao H; Liu T; Wang G; Gao Y; Yin L; Peng Y; Lyu N; Zhang K; Gao W; Wu J; Jiang K; Wei J; Miao Y
Langenbecks Arch Surg; 2019 Mar; 404(2):175-182. PubMed ID: 30826926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
